Results 41 to 50 of about 690,085 (165)

Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU

open access: yesRevista de Gastroenterología de México (English Edition), 2022
Introduction: Inflammatory bowel disease (IBD) is a chronic and incurable entity. The aim of the Pan American Crohn's and Colitis Organisation (PANCCO) is to create awareness of IBD, with special emphasis on Latin America, and the primary objective of ...
J.K. Yamamoto-Furusho   +13 more
doaj   +1 more source

Updated insights into the molecular pathogenesis of canine atopic dermatitis

open access: yesVeterinary Dermatology, Volume 36, Issue 4, Page 375-384, August 2025.
Abstract Atopic dermatitis (AD) is a common and chronic inflammatory skin disease with frequent relapses. The genomics revolution has greatly contributed and revolutionised our knowledge of human AD; understanding the molecular skin fingerprint of AD and associated pathogenic immune pathways has led to preclinical assessments of several novel ...
Frane Banovic
wiley   +1 more source

TRATAMIENTO QUIRÚRGICO DE LA COLITIS ULCEROSA

open access: yesRevista Médica Clínica Las Condes, 2019
Resumen: El tratamiento médico de pacientes con colitis ulcerosa se basa en aminosalicilatos, corticoides, inmunomoduladores y en los últimos años en terapia biológica predominantemente con anti-TNF.
Udo Kronberg
doaj   +1 more source

Epidemiología, carga de la enfermedad y tendencias de tratamiento de la enfermedad inflamatoria intestinal en México

open access: yesRevista de Gastroenterología de México, 2020
Resumen: Introducción y objetivos: En México no existe información sistematizada para determinar/monitorizar la carga de la enfermedad inflamatoria intestinal (EII).
J.K. Yamamoto-Furusho   +6 more
doaj   +1 more source

Macronutrients as Regulators of Intestinal Epithelial Permeability: Where Do We Stand?

open access: yesComprehensive Reviews in Food Science and Food Safety, Volume 24, Issue 3, May 2025.
ABSTRACT The intestinal barrier function (IBF) is essential for intestinal homeostasis. Its alterations have been linked to intestinal and systemic disease. Regulation of intestinal permeability is key in the maintenance of the IBF, in which the intestinal epithelium and tight junctions, the mucus layer, sIgA, and antimicrobial peptides are important ...
Olga Martínez‐Augustin   +9 more
wiley   +1 more source

The most highly cited articles of the Revista de Gastroenterología de México over a 22-year period (1996-2018)

open access: yesRevista de Gastroenterología de México (English Edition), 2021
Introduction and aim: The Revista de Gastroenterología de México (RGM), founded in 1935, is one of the most influential journals of scientific dissemination in Mexico and Latin America.
G.E. Sánchez-Morales   +4 more
doaj   +1 more source

Hypoxia inducible factor 3‐alpha promotes a malignant phenotype in colorectal cancer cells

open access: yesIUBMB Life, Volume 77, Issue 2, February 2025.
Abstract Colorectal cancer (CRC) is the third most common cancer worldwide. Hypoxia is a hallmark of the tumor microenvironment, and cellular adaptation to it is primarily mediated by the family of Hypoxia‐inducible factors (HIFs) HIF‐1α, HIF‐2α, and HIF‐3α. However, in contrast to HIF‐1α and HIF‐2α, a specific role for HIF‐3α in cancer biology has not
Alejandro Lopez‐Mejia   +7 more
wiley   +1 more source

A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease

open access: yesAnales de Pediatría (English Edition), 2018
Background and objectives: Adalimumab (ADA), a monoclonal humanised anti-TNF antibody, is usually prescribed as a second-line treatment in paediatric Crohn's disease (CD) patients who have become unresponsive or developed intolerance to infliximab (IFX).
Víctor Manuel Navas-López   +7 more
doaj   +1 more source

Linfoma colorrectal primario en paciente con colitis ulcerosa en tratamiento con anti-factor de necrosis tumoral e infección por citomegalovirus

open access: yesEndoscopia, 2021
El uso prolongado de terapia anti-factor de necrosis tumoral es cada vez más frecuente en los pacientes con enfermedad inflamatoria intestinal.
J. Alberto Romero-Lozanía   +5 more
doaj   +1 more source

Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe

open access: yesPharmacoepidemiology and Drug Safety, Volume 33, Issue 8, August 2024.
ABSTRACT Purpose Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA), a European Medicines Agency–funded project (EUPAS39322), defined a set of metadata to describe real‐world data sources (RWDSs) and piloted metadata collection in a prototype catalogue to assist investigators from data source discoverability ...
Romin Pajouheshnia   +46 more
wiley   +1 more source

Home - About - Disclaimer - Privacy